Hałasa, R.; Turecka, K.; Mizerska, U.; Krauze-Baranowska, M. Anti-Helicobacter Pylori Biofilm Extracts from Rubus Idaeus and Rubus Occidentalis. Pharmaceutics 2024, 16, 501, doi:10.3390/pharmaceutics16040501.
Hałasa, R.; Turecka, K.; Mizerska, U.; Krauze-Baranowska, M. Anti-Helicobacter Pylori Biofilm Extracts from Rubus Idaeus and Rubus Occidentalis. Pharmaceutics 2024, 16, 501, doi:10.3390/pharmaceutics16040501.
Hałasa, R.; Turecka, K.; Mizerska, U.; Krauze-Baranowska, M. Anti-Helicobacter Pylori Biofilm Extracts from Rubus Idaeus and Rubus Occidentalis. Pharmaceutics 2024, 16, 501, doi:10.3390/pharmaceutics16040501.
Hałasa, R.; Turecka, K.; Mizerska, U.; Krauze-Baranowska, M. Anti-Helicobacter Pylori Biofilm Extracts from Rubus Idaeus and Rubus Occidentalis. Pharmaceutics 2024, 16, 501, doi:10.3390/pharmaceutics16040501.
Abstract
Helicobacter pylori infections are still an urgent and hot topic. This is related to the involvement of H. pylori in human diseases (including gastric diseases, gastric adenocarcinoma, mucosa-associated lymphoid tissue lymphoma, and diabetes), the number of which is constantly increasing. At the same time, agents effective against these bacteria are decreasing due to spreading resistance. Our research focused on extracts of the Rubus genus, commonly present in Central and Eastern Europe and very useful in folk medicine. Results have shown that the extract from Rubus idaeus 'Willamette' shoots, and the extract from R. idaeus 'Poranna Rosa' fruits and R. idaeus 'Laszka' R. occidentalis Litacz' fruits prevent the formation of biofilm by H. pylori on intravenous infusions (they reduce living cells, which was detected using triphenyl tetrazolium chloride (TTC) as a dye) at concentrations of 6.65 and 16.65 mg/mL, respectively. However, the living bacteria in the formed biofilm are affected by the extract from the shoots of R. idaeus 'Willamette' and the fruit of R. idaeus 'Poranna Rosa' at a concentration of 16.65 mg/ml, and the remaining extracts at a concentration of 33.3 mg/ml. The results of the study of interactions of extracts from Rubus sp. and the 2 antibiotics against H. pylori planktonic bacteria showed doxycycline synergism with all tested extracts, but only the extract of R. occidentalis 'Litacz' with levofloxacin. The remaining tested extracts showed indifference with levofloxacin. However, studies on the interaction between antibiotics and extracts of R. idaeus 'Willamette' shoot showed synergy with doxycycline and levofloxacin, additivity with amoxicillin and clarithromycin, and indifference with metronidazole. The tests were carried out on fragments of intravenous infusions with TTC as a dye. The tested extracts may be elements of broadly understood anti-H. pylori therapy.
Medicine and Pharmacology, Epidemiology and Infectious Diseases
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
